Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with type 2 diabetes also had a fivefold higher risk for liver cancer.
However, researchers saw little difference across racial groups in HBV treatment initiation among those who were eligible.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.
Generic drugs are cheaper and lead to better treatment compliance compared with brand-name drugs.
Drug-related mortality, including overdose, was the leading cause of death.
Black people are at greater risk of developing severe liver fibrosis. A study suggests ways to mitigate that risk.
The device may be approved for clinical use within the next three years.
Blood levels of a particular protein helped predict which patients would survive without a liver transplant.
People who are living with all three viruses have a greater likelihood of progressing to end-stage liver disease.
As unexplained hepatitis cases in children rise globally, countries must unite to eliminate viral hepatitis.
Age and transplant drugs can affect recurrence of autoimmune hepatitis.
Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.
People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.
I always wanted to go to hear firsthand how I could continue to live with end-stage liver failure.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.